共查询到20条相似文献,搜索用时 134 毫秒
1.
肿瘤疾病负担研究进展 总被引:1,自引:0,他引:1
疾病负担(Burden of Diseue,BOD)是指疾病所造成的对健康、经济、资源的损失与产生的生物、心理和对社会的危害,以及对疾病结局如死亡、失能和康复所带来的后果和影响.文章对国内外疾病负担以及和肿瘤疾病负担的研究进展进行了综述. 相似文献
2.
媒传疾病的疾病负担是指媒传疾病所致患者伤残及早逝对健康寿命、社会经济造成的损失和影响,包括经济负担和个体家庭负担两个方面。伤残调整寿命年是衡量疾病负担的综合指标。疾病经济负担分为直接经济负担、间接经济负担和无形经济负担,直接经济负担的估算方法有微观成本法和宏观成本法,间接经济负担的估算方法包括人力资本法和摩擦成本法,无形经济负担一般用支付意愿法估算。目前卫生经济学评价方法主要是成本-效用分析、成本-效益分析和成本-效果分析法。本文对疟疾等媒传疾病的疾病负担估算方法进行综述,以比较不同方法对指标选择的要求及其应用价值。 相似文献
3.
诺如病毒变异快、感染剂量低、传播途径多样,具有高传染性和快速传播的特征。诺如病毒感染是导致腹泻疾病的主要病因,近年来我国诺如病毒暴发疫情整体呈现上升趋势,主要发生在小学和托幼机构,给家庭和社会造成较大的疾病负担。本文就诺如病毒的病原学特征、流行情况和疾病负担等进行综述,为疾病监测和防控提供参考。 相似文献
4.
棘球蚴病是一种严重危害人民健康和畜牧业发展的寄生虫病,日益受到社会各界的关注.该文从流行病学评价、经济负担等方面对棘球蚴病的疾病负担进行综述. 相似文献
5.
棘球蚴病是一种严重危害人民健康和畜牧业发展的寄生虫病,日益受到社会各界的关注.该文从流行病学评价、经济负担等方面对棘球蚴病的疾病负担进行综述. 相似文献
6.
棘球蚴病是一种严重危害人民健康和畜牧业发展的寄生虫病,日益受到社会各界的关注.该文从流行病学评价、经济负担等方面对棘球蚴病的疾病负担进行综述. 相似文献
7.
8.
9.
10.
文章对卒中疾病负担评价的国内外进展、目前应用的方法和指标等进行了综述。目前,潜在寿命损失年、失能调整生命年是评价卒中患者群体死亡和失能等负担较好的指标。同时,家庭和社会负担也是卒中疾病负担评价中不可忽视的方面。 相似文献
11.
Parham Sendi Sarah Drger Bettina Batzer Susanne Walser Marc Dangel Andreas F. Widmer 《Influenza and other respiratory viruses》2020,14(1):72-76
We report an influenza outbreak in a 75‐bed rehabilitation centre and present the detailed microeconomic impact that it had during the season 2016/2017. The direct medical, direct non‐medical and indirect costs were calculated. The outbreak included 18 patients with influenza and 8 contact patients, leading to 86 days with isolation precautions. During the outbreak month, 25 (15%) employees were absent from work for 89 days (mean 3.6 days, SD ± 1.8), and during the entire influenza season 33 for 175 (5.3 ± SD 4.6) days, respectively. The economic burden related to the outbreak was 114 373 CHF (106 890 €, 112 131 $). 相似文献
12.
鄱阳湖地区位于东亚-澳大利亚迁徙路线上,流感病毒能通过野鸟迁徙传播到其他国家和大洲。频繁的家禽贸易同样能使流感病毒基因间不断发生重配,导致病毒持续进化和传播。此外家禽的长距离运输和野鸟的捕捉贩卖等也是影响病毒传播的因素。本文总结了鄱阳湖当地禽流感病毒的流行、分布状况以及影响病毒传播的因素。长期监测能更好的了解禽流感病毒的分布和流行规律,更好地对禽流感进行预警和防控。 相似文献
13.
John Klena Shali Liu Youxing Peng Hui Yang Jun Luo Jiandong Zheng Maoyi Chen Zhibin Peng Nijuan Xiang Xixiang Huo Lin Xiao Hui Jiang Hui Chen Yuzhi Zhang Xuesen Xing Zhen Xu Zijian Feng Faxian Zhan Weizhong Yang Timothy M. Uyeki Yu Wang Jay K. Varma 《Influenza and other respiratory viruses》2014,8(1):53-65
14.
15.
16.
17.
甲型流感病毒是一种人兽共患病的病原体,它可以引起季节性流感和人感染动物源性流感等多种疾病,具有传染性强、变异率高、危害性大等特点,一直以来都是监测及研究的重点对象.血凝素作为病毒表面的重要糖蛋白之一,在病毒的宿主嗜性、生命周期、变异进化,防控工作的监测监查以及相关抗流感药物的研发等方面地位突出.本文从形态结构、功能作用... 相似文献
18.
禽流感病毒的天然宿主有水禽、野生鸟类和迁移性候鸟等。禽流感病毒主要感染家禽,并造成严重的经济损失,有的禽流感病毒的亚型还可感染人,是在人群中引发流感大流行的一个潜在危险因素。早期监测、快速准确检测和诊断禽流感病毒有助于预测、评估和了解禽流感病毒的变异趋势、流行传播规律,并及时应对突发的禽流感疫情。本文将简述禽流感病毒的监测及诊断方法。 相似文献
19.
Assessing uncertainty in the burden of hepatitis C virus: Comparison of estimated disease burden and treatment costs in the UK 下载免费PDF全文
F. Gubay R. Staunton C. Metzig I. Abubakar P. J. White 《Journal of viral hepatitis》2018,25(5):514-523
Hepatitis C virus (HCV) is a major and growing public health concern. We need to know the expected health burden and treatment cost, and understand uncertainty in those estimates, to inform policymaking and future research. Two models that have been important in informing treatment guidelines and assessments of HCV burden were compared by simulating cohorts of individuals with chronic HCV infection initially aged 20, 35 and 50 years. One model predicts that health losses (measured in quality‐adjusted life‐years [QALYs]) and treatment costs decrease with increasing initial age of the patients, whilst the other model predicts that below 40 years, costs increase and QALY losses change little with age, and above 40 years, they decline with increasing age. Average per‐patient costs differ between the models by up to 38%, depending on the patients' initial age. One model predicts double the total number, and triple the peak annual incidence, of liver transplants compared to the other model. One model predicts 55%‐314% more deaths than the other, depending on the patients' initial age. The main sources of difference between the models are estimated progression rates between disease states and rates of health service utilization associated with different disease states and, in particular, the age dependency of these parameters. We conclude that decision‐makers need to be aware that uncertainties in the health burden and economic cost of HCV disease have important consequences for predictions of future need for care and cost‐effectiveness of interventions to avert HCV transmission, and further quantification is required to inform decisions. 相似文献